Please login to the form below

Not currently logged in
Email:
Password:

NovoEight

This page shows the latest NovoEight news and features for those working in and with pharma, biotech and healthcare.

New data could unlock bigger market for Roche’s Hemlibra

New data could unlock bigger market for Roche’s Hemlibra

Novo Nordisk is developing a once-weekly version of its established NovoEight product - called N8-GP - that could be filed next year.

Latest news

  • US approval for Novo's Factor XIII drug Tretten US approval for Novo's Factor XIII drug Tretten

    In October, Novo secured US approval for NovoEight, a new long-acting Factor VIII for people with haemophilia A (turoctocog alfa), while it also has NN7999, a long-acting recombinant coagulation

  • Novo Nordisk wins US approval for haemophilia treatment Novo Nordisk wins US approval for haemophilia treatment

    US regulators have approved NovoEight, Novo Nordisk's new treatment for people with haemophilia A. ... The US approval follows a positive recommendation for NovoEight from the European Medicines Agency (EMA) made last month.

  • EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

    Novo Nordisk's haemophilia drug. Among the drugs backed by the CHMP, which provides guidance to the European Medicines Agency (EMA), was Novo Nordisk's NovoEight (turoctocog alfa) for use in ... NovoEight has also been filed for approval in the US, Japan,

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics